Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Clinical trials sponsored by Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., explained in plain language.
A Chinese vaccine manufacturer, subsidiary of Chongqing Zhifei Biological Products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Could a simple skin test uncover silent TB?
Diagnosis CompletedThis study tested a new skin test called C-TST to find latent (hidden) tuberculosis infections in 300 adults in Indonesia who were close contacts of TB patients. Participants received both the skin test and a standard blood test (IGRA) to see how well the new test worked. The goa…
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Could a new skin test better detect TB in seniors?
Diagnosis CompletedThis study tested a new skin test called EC to see if it can accurately diagnose tuberculosis (TB) infection in adults aged 65 and older. Researchers compared EC with a standard TB skin test (TB-PPD) and a blood test (T-SPOT) in 780 participants, including TB patients and healthy…
Phase 3 • Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC